Fucosterol exerts an anti-atherosclerotic action via NF-κB and p38/Erk MAPK signaling pathways

Tiancheng Liu1, Mengli Zhang1, Xian Wu1

  • 1Department of Emergency, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, China.

Atherosclerosis Plus
|June 12, 2025
PubMed
Abstract

Insights

Fucosterol, a compound from brown algae, effectively reduces atherosclerosis by inhibiting inflammation and oxidative stress in mice and human cells. This study highlights its potential therapeutic benefits for cardiovascular health.

Area of Science:

  • Marine natural products
  • Cardiovascular research
  • Molecular biology

Background:

  • Fucosterol is a sterol derived from brown algae with known anti-inflammatory and antidiabetic properties.
  • Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.

Purpose of the Study:

  • To investigate the anti-atherosclerosis effects of fucosterol both in vivo and in vitro.
  • To elucidate the underlying molecular mechanisms of fucosterol's action on atherosclerosis.

Main Methods:

  • ApoE-/- mice on a high-fat diet were treated with fucosterol; atherosclerotic lesions and lipid levels were assessed.
  • Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low-density lipoprotein (ox-LDL) to model atherosclerosis in vitro.
  • Inflammatory markers, oxidative stress, cell viability, apoptosis, and key signaling pathways (NF-κB, MAPK) were analyzed.

Main Results:

  • Fucosterol significantly reduced atherosclerotic plaques and lipid levels in mice.
  • It alleviated macrophage infiltration, inflammation, and oxidative stress in vivo and in vitro.
  • Fucosterol suppressed ox-LDL-induced inflammation, oxidative stress, and apoptosis in HUVECs, and inhibited PCSK9 expression.

Conclusions:

  • Fucosterol demonstrates potent anti-atherosclerosis effects by mitigating hyperlipidemia, inflammation, and oxidative stress.
  • The findings suggest fucosterol as a potential therapeutic agent for preventing and treating atherosclerosis.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Inflammation01:38

Inflammation

Overview
53.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K